Literature DB >> 1393433

Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors.

A P Sene1, L Hunt, R F McMahon, R N Carroll.   

Abstract

A series of 155 patients who underwent nephrectomy for renal carcinoma between 1965 and 1985 at Manchester Royal Infirmary were analysed for survival in relationship to presenting features, surgical staging and histopathology. Univariate and multivariate analyses were carried out. Five-year survival estimates for stage 1 disease were 81%, for stage 2 disease 65%, for stage 3 disease 39% and for stage 4 disease 6%. An erythrocyte sedimentation rate (ESR) greater than 30 mm/h was associated with worse survival and a history of hypertension was associated with better survival. Renal vein invasion alone was related to worse survival. Perinephric fat invasion was also associated with worse survival and this association in the multivariate analysis was more significant than expected, suggesting that the principles of radical surgery should be observed. The presence of granular cells as opposed to clear cells worsened survival. Patients with papillary tumours had a better survival than those with solid tumours.

Entities:  

Mesh:

Year:  1992        PMID: 1393433     DOI: 10.1111/j.1464-410x.1992.tb15689.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  12 in total

1.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

Review 2.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

3.  Impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy performed with the indication of renal cell carcinoma.

Authors:  Abdulmuttalip Şimşek; Onur Küçüktopcu; Fatih Akbulut; Faruk Özgör; Elif Küçüktopcu; Metin Savun; Yalçın Berberoğlu; Gökhan Gürbüz
Journal:  Turk J Urol       Date:  2015-03

4.  Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.

Authors:  Dionisios Mitropoulos; Aspasia Kiroudi; Evangelia Christelli; Efraim Serafetinidis; Anastasios Zervas; Ioannis Anastasiou; Constantinos Dimopoulos
Journal:  Urol Res       Date:  2004-09-07

5.  Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma.

Authors:  James S Magera; Bradley C Leibovich; Christine M Lohse; Shomik Sengupta; John C Cheville; Eugene D Kwon; Michael L Blute
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

6.  Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature.

Authors:  John Syrios; Georgios Kechagias; Nicolas Tsavaris
Journal:  J Med Case Rep       Date:  2012-09-14

7.  Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.

Authors:  Brian W Cross; Timothy V Johnson; Austin B Derosa; Kenneth Ogan; John G Pattaras; Peter T Nieh; Omer Kucuk; Wayne B Harris; Viraj A Master
Journal:  Int J Surg Oncol       Date:  2012-07-29

8.  Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.

Authors:  Patrick Schöffski; Vincente Guillem; Margarita Garcia; Fernando Rivera; Josep Tabernero; Martin Cullell; Jose Antonio Lopez-Martin; Patricia Pollard; Herlinde Dumez; Xavier Garcia del Muro; Luis Paz-Ares
Journal:  Mar Drugs       Date:  2009-03-05       Impact factor: 5.118

9.  Embolisation of cancer: what is the evidence?

Authors:  J A Goode; M B Matson
Journal:  Cancer Imaging       Date:  2004-09-17       Impact factor: 3.909

10.  Metastatic renal cell carcinoma to the jaws: report of cases.

Authors:  Louqiang Zhang; Hongbin Yang; Xuebin Zhang
Journal:  World J Surg Oncol       Date:  2014-07-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.